Not Yet Recruiting
Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia
NCT07315373
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
Not specified